Journal articles
A novel approach to specific allergy treatment: the recombinant allergen-S-layer fusion protein rSbsC-Bet v 1 matures dendritic cells that prime Th0/Th1 and IL-10-producing regulatory T cells.
Gerstmayr M, Ilk N, Schabussova I, Jahn-Schmid B, Egelseer E, Sleytr U, et al. A novel approach to specific allergy treatment: the recombinant allergen-S-layer fusion protein rSbsC-Bet v 1 matures dendritic cells that prime Th0/Th1 and IL-10-producing regulatory T cells. Journal of Immunology. 2007;179(11):7270-5.
:
BOKU Autoren
Eva Maria Egelseer
Dr. Eva Maria Egelseer
Uwe B. Sleytr
em.o.Univ.Prof. Dipl.-Ing.Dr. Uwe B. Sleytr
Nicola Ilk
Dipl.Biol.Dr. Nicola Ilk
